AGP Executive Report
Last update: 10 hours agoMozambique Health Funding: France, via Gavi, will disburse $275m over five years to back Mozambique’s vaccine and disease-control work, including a new type B polio vaccine rollout, while highlighting the country’s integrated community health delivery model. Dengue Vaccine Push (Africa): KNUST has joined the DENSTAR project to speed Phase III trials for a single-dose dengue vaccine (DengiAll), aiming to cut dengue’s growing burden across sub-Saharan Africa. HIV Patent Fight (Regional): PATAM and TWN have challenged a broad Gilead HIV patent application at ARIPO, arguing earlier disclosures and prior science should block overly wide protection across ARIPO contracting states. Xenophobia & Health Safety (South Africa): WHO chief Tedros calls the anti-foreigner violence a “tragic betrayal,” citing deaths and mass displacement, while South Africa’s presidency and DIRCO say some WHO-linked claims are inaccurate and that organised crime is under investigation. Mozambique in the News: UAE and Mozambique presidents discussed cooperation on investment and renewable energy. Community Health & Environment: A “Smart Nappy” project is promoting reusable nappies to tackle nappy pollution and protect local freshwater systems.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
